{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:21Z","timestamp":1793723781445,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.109969","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T22:17:03Z","timestamp":1698877023000},"page":"109969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline"],"prefix":"10.1016","volume":"190","author":[{"given":"R.S.","family":"Guninski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bellut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dahele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mancosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Munck af Rosenschold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.F.A.R.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109969_b0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s43856-023-00304-x","article-title":"Future trends in incidence and long-term survival of metastatic cancer in the United States","volume":"3","author":"Hudock","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/j.radonc.2023.109969_b0010","article-title":"Randomized controlled study of pain education in patients receiving radiotherapy for painful bone metastases","volume":"1","author":"Geerling","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2022.06.002","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases","volume":"1","author":"Oldenburger","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2022.05.024","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases","volume":"1","author":"van der Velden","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109969_b0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","article-title":"Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy","volume":"128","author":"Sprave","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0045","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.21873\/anticanres.12814","article-title":"Quality of Life Following Stereotactic Body Radiotherapy <em>Versus<\/em> Three-Dimensional Conformal Radiotherapy for Vertebral Metastases: Secondary Analysis of an Exploratory Phase II Randomized Trial","volume":"38","author":"Sprave","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109969_b0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","article-title":"Pain Response After stereotactic body radiation therapy versus conventional radiation therapy in patients with bone metastases\u2014A phase 2 randomized controlled trial within a prospective cohort","volume":"110","author":"Pielkenrood","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0055","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2019.06.382","article-title":"Radiosurgery compared to external beam radiotherapy for localized spine metastasis: phase III results of NRG oncology\/RTOG 0631","volume":"105","author":"Ryu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0060","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0065","doi-asserted-by":"crossref","unstructured":"Mercier C. Single fraction SBRT vs 3D-CRT for painful bone metastases: a single-blind phase 3 RCT (NCT03831243). ESTRO Annu Meet 2023 Vienna. 2023 May 15.","DOI":"10.1016\/S0167-8140(23)08703-0"},{"key":"10.1016\/j.radonc.2023.109969_b0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2015.05.035","article-title":"Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery","volume":"93","author":"Moussazadeh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.radonc.2016.12.031","article-title":"Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review","volume":"122","author":"Chow","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0080","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: a systematic review","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","article-title":"Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy","volume":"118","author":"Guckenberger","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0090","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ijrobp.2015.12.004","article-title":"Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases","volume":"94","author":"Klement","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2017.01.013","article-title":"Stereotactic body radiotherapy for oligo-metastatic liver disease \u2013 Influence of pre-treatment chemotherapy and histology on local tumor control","volume":"123","author":"Klement","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2019.08.026","article-title":"Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: long-term results of a prospective phase 2 study","volume":"1","author":"Mantel","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0105","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","volume":"110","author":"Sahgal","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","article-title":"Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites","volume":"93","author":"Forquer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0120","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/cncr.22299","article-title":"Radiosurgery for the treatment of spinal lung metastases","volume":"107","author":"Gerszten","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109969_b0125","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/cncr.21467","article-title":"Single-fraction radiosurgery for the treatment of spinal breast metastases","volume":"104","author":"Gerszten","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109969_b0130","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1016\/j.ijrobp.2011.11.036","article-title":"Stereotactic Body Radiation Therapy in Spinal Metastases","volume":"82","author":"Ahmed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3171\/2012.8.SPINE12303","article-title":"Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma: Clinical article","volume":"17","author":"Balagamwala","year":"2012","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0140","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1002\/cncr.27530","article-title":"Phase 1\/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases","volume":"118","author":"Garg","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109969_b0145","first-page":"2","article-title":"Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach","author":"Gill","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1470-2045(11)70384-9","article-title":"Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1\u20132 trial","volume":"13","author":"Wang","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0155","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1\u20133) spine metastases: Phase 2 results","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0160","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3171\/2014.7.SPINE13895","article-title":"Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture: clinical article","volume":"21","author":"Thibault","year":"2014","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clon.2015.01.035","article-title":"Hypofractionated Stereotactic Body Radiotherapy in Spinal Metastasis \u2014 With or Without Epidural Extension","volume":"27","author":"Anand","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0170","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"92","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/2014.9.SPINE1482","article-title":"Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma","volume":"22","author":"Sellin","year":"2015","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3171\/2014.10.SPINE14252","article-title":"Stereotactic radiosurgery for spinal metastases with or without separation surgery","volume":"22","author":"Bate","year":"2015","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0185","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3171\/2015.10.SPINE141261","article-title":"Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation","volume":"24","author":"Jawad","year":"2016","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7785\/tcrt.2012.500411","article-title":"Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?","volume":"14","author":"Park","year":"2015","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.109969_b0195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/thy.2016.0046","article-title":"Spine stereotactic radiosurgery for patients with metastatic thyroid cancer: secondary analysis of phase I\/II trials","volume":"26","author":"Bernstein","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.radonc.2023.109969_b0200","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3171\/2015.8.SPINE15844","article-title":"Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I\/II trials","volume":"24","author":"Ghia","year":"2016","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3171\/2015.6.SPINE15190","article-title":"Stereotactic radiosurgery for metastasis to the craniovertebral junction preserves spine stability and offers symptomatic relief","volume":"24","author":"Azad","year":"2016","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0215","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3340\/jkns.2016.59.1.37","article-title":"Radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from hepatocellular carcinoma : a multicenter","volume":"59","author":"Sohn","year":"2016","journal-title":"Matched-Pair Study J Korean Neurosurg Soc"},{"key":"10.1016\/j.radonc.2023.109969_b0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3171\/2016.1.SPINE151166","article-title":"The use of spine stereotactic radiosurgery for oligometastatic disease","volume":"25","author":"Ho","year":"2016","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0225","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.clon.2017.02.004","article-title":"Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases","volume":"29","author":"Chang","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/01616412.2017.1295197","article-title":"Stereotactic radiosurgery and stereotactic fractionated radiotherapy for metastatic tumors of the spine","volume":"39","author":"Mariano","year":"2017","journal-title":"Neurol Res"},{"key":"10.1016\/j.radonc.2023.109969_b0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","article-title":"Imaging-Based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine Stereotactic Body Radiation Therapy (SBRT)","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0240","article-title":"Stereotactic body radiotherapy for spinal metastases: clinical experience in 134 cases from a single Japanese institution","volume":"1","author":"Ito","year":"2018","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.109969_b0245","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/2016.4.SPINE16229","article-title":"Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma","volume":"25","author":"Miller","year":"2016","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0250","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/j.wneu.2018.10.044","article-title":"Oligometastatic disease state is associated with improved local control in patients undergoing three or five fraction spine stereotactic body radiotherapy","volume":"1","author":"Silva","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2023.109969_b0255","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jjco\/hyz130","article-title":"A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases","volume":"49","author":"Ito","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2019.06.003","article-title":"Low incidence of late failure and toxicity after spine stereotactic radiosurgery: secondary analysis of phase I\/II trials with long-term follow-up","volume":"1","author":"Ning","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0265","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4143\/crt.2018.653","article-title":"The feasibility of spinal stereotactic radiosurgery for spinal metastasis with epidural cord compression","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.109969_b0270","doi-asserted-by":"crossref","first-page":"9.aspx","DOI":"10.1097\/BRS.0000000000003087","article-title":"Clinical efficacy of frameless stereotactic radiosurgery in the management of spinal metastases from thyroid carcinoma","volume":"44","author":"Hariri","year":"2019","journal-title":"Spine"},{"key":"10.1016\/j.radonc.2023.109969_b0275","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clon.2020.02.030","article-title":"Vertebral fractures following stereotactic body radiotherapy for spine oligometastases: a multi-institutional analysis of patient outcomes","volume":"32","author":"Abbouchie","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0280","doi-asserted-by":"crossref","unstructured":"Yeung WM (Eva). Stereotactic body radiotherapy as a primary treatment for spinal metastasis: a single institution experience. Ann Palliat Med 2020;9 Ann Palliat Med. 2020 [cited 2020 Jan 1]; Available from: https:\/\/apm.amegroups.com\/article\/view\/57104.","DOI":"10.21037\/apm-19-131"},{"key":"10.1016\/j.radonc.2023.109969_b0285","article-title":"Stereotactic body radiation therapy with simultaneous integrated boost in patients with spinal metastases","volume":"1","author":"Pontoriero","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.109969_b0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11060-020-03534-4","article-title":"Stereotactic radiosurgery for the treatment of bulky spine metastases","volume":"148","author":"Kowalchuk","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109969_b0295","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190655","article-title":"MRI-guided stereotactic ablative radiation therapy of spinal bone metastases: a preliminary experience","volume":"93","author":"Llorente","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109969_b0300","first-page":"756","article-title":"Stereotactic ablative radiation therapy for spinal metastases: experience at a single Brazilian institution","volume":"26","author":"Marta","year":"2021","journal-title":"Rep Pract Oncol Radiother J Gt Cancer Cent Poznan Pol Soc Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0305","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13014-014-0226-2","article-title":"Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis","volume":"9","author":"Guckenberger","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0310","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jjco\/hyaa128","article-title":"Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer","volume":"50","author":"Ito","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","article-title":"Local control and patterns of failure for \u201cRadioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cRadiosensitive\u201d reference","volume":"152","author":"Zeng","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109969_b0320","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2020.12.045","article-title":"Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases","volume":"110","author":"Guckenberger","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3171\/2020.1.SPINE191260","article-title":"Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin","volume":"33","author":"Sandhu","year":"2020","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0330","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3171\/2020.6.SPINE20349","article-title":"Patient outcomes and tumor control in single-fraction versus hypofractionated stereotactic body radiation therapy for spinal metastases: Presented at the 2020 AANS\/CNS Joint Section on Disorders of the Spine and Peripheral Nerves","volume":"34","author":"Park","year":"2021","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0335","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3171\/2020.6.SPINE20861","article-title":"Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region","volume":"34","author":"Kowalchuk","year":"2021","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0340","first-page":"95","article-title":"A comparison of stereotactic body radiation therapy for metastases to the sacral spine and treatment of the thoracolumbar spine","volume":"7","author":"Kowalchuk","year":"2020","journal-title":"J Radiosurgery SBRT"},{"key":"10.1016\/j.radonc.2023.109969_b0345","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11060-020-03522-8","article-title":"Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring","volume":"148","author":"Gjyshi","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109969_b0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.radonc.2020.06.009","article-title":"Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis","volume":"1","author":"Chen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0355","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3171\/2019.12.SPINE191269","article-title":"Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience","volume":"32","author":"Boyce-Fappiano","year":"2020","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0360","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.wneu.2019.10.094","article-title":"Comparison of Clinical Outcomes Stratified by Target Delineation for Patients Undergoing Stereotactic Body Radiotherapy for Spinal Metastases","volume":"1","author":"Attiah","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2023.109969_b0365","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3171\/2019.9.SPINE19377","article-title":"Spine radiosurgery in adolescents and young adults: early outcomes and toxicity in patients with metastatic Ewing sarcoma and osteosarcoma","volume":"32","author":"Parsai","year":"2020","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0370","first-page":"e4742","article-title":"Spine stereotactic radiosurgery for metastatic pheochromocytoma","volume":"11","author":"Mesko","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.radonc.2023.109969_b0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.prro.2018.11.009","article-title":"Analysis of local control and pain control after spine stereotactic radiosurgery reveals inferior outcomes for hepatocellular carcinoma compared with other radioresistant histologies","volume":"9","author":"McGee","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.adro.2018.04.002","article-title":"Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases","volume":"3","author":"Mehta","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0390","first-page":"99","article-title":"Pain flare after stereotactic radiosurgery for spine metastases","volume":"5","author":"Balagamwala","year":"2018","journal-title":"J Radiosurgery SBRT"},{"key":"10.1016\/j.radonc.2023.109969_b0400","doi-asserted-by":"crossref","first-page":"72860","DOI":"10.18632\/oncotarget.20529","article-title":"Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture","volume":"8","author":"Yoo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2023.109969_b0405","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2016.8.SPINE16412","article-title":"Spine stereotactic radiosurgery for the treatment of multiple myeloma","volume":"26","author":"Miller","year":"2017","journal-title":"J Neurosurg Spine SPI"},{"key":"10.1016\/j.radonc.2023.109969_b0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-017-2428-6","article-title":"Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy","volume":"133","author":"Gestaut","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109969_b0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10585-015-9764-8","article-title":"Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinal metastases","volume":"33","author":"Germano","year":"2016","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.radonc.2023.109969_b0420","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2013.12.042","article-title":"Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine","volume":"88","author":"Folkert","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109969_b0425","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jjco\/hyt050","article-title":"High-dose radiotherapy using helical tomotherapy for vertebral metastasis: early clinical outcomes and cord dose specification","volume":"43","author":"Lee","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109969_b0430","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7785\/tcrt.2012.500329","article-title":"Stereotactic body radiotherapy with helical tomotherapy for pain palliation in spine metastasis","volume":"12","author":"Kim","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.109969_b0435","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11060-009-9814-7","article-title":"Assessment of image-guided CyberKnife@ radiosurgery for metastatic spine tumors","volume":"94","author":"Tsai","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109969_b0440","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.wneu.2014.08.061","article-title":"Radiosurgery for metastatic disease at the craniocervical junction","volume":"82","author":"Tuchman","year":"2014","journal-title":"World Neurosurg"},{"key":"10.1016\/j.radonc.2023.109969_b0445","first-page":"51","article-title":"Stereotactic radiosurgery for high-grade metastatic epidural cord compression","volume":"3","author":"Lee","year":"2014","journal-title":"J Radiosurgery SBRT"},{"issue":"6","key":"10.1016\/j.radonc.2023.109969_bib446","doi-asserted-by":"crossref","first-page":"883","DOI":"10.5603\/RPOR.a2021.0099","article-title":"Local control of 1\u20135 fraction radiotherapy regimens for spinal metastases: an analysis of the impacts of biologically effective dose and primary histology","volume":"26","author":"Kowalchuk","year":"2021","journal-title":"Rep Pract Oncol Radiother"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T04:11:12Z","timestamp":1734235872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":87,"alternative-id":["S0167814023898632"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109969"}}